Indofarma Tbk (INAF) — Cash Flow Quality Index
Indofarma Tbk (INAF) has a Cash Flow Quality Index of 25.56x as of September 2021. Operating cash flow of Rp47.20 Billion exceeds net income of Rp1.85 Billion, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of Indofarma Tbk to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Indofarma Tbk Cash Flow Quality Index (2000–2020)
Historical Cash Flow Quality Index for Indofarma Tbk across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check INAF capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Indofarma Tbk (2000–2020)
Year-by-year earnings quality comparison for Indofarma Tbk. For live market cap and the full company financial profile, see Indofarma Tbk (INAF) market capitalisation.
| Year | Quality Index | Operating CF (IDR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 1687.69x | Rp46.55 Billion | Rp27.58 Million | ▲ +64522.4% |
| 2019 | 2.61x | Rp20.79 Billion | Rp7.96 Billion | ▼ -87.2% |
| 2015 | 20.45x | Rp134.28 Billion | Rp6.57 Billion | ▼ -84.0% |
| 2014 | 127.55x | Rp148.73 Billion | Rp1.17 Billion | ▲ +13312.9% |
| 2012 | -0.97x | Rp-40.91 Billion | Rp42.38 Billion | ▼ -221.2% |
| 2011 | 0.80x | Rp29.40 Billion | Rp36.92 Billion | ▼ -57.9% |
| 2010 | 1.89x | Rp23.71 Billion | Rp12.55 Billion | ▼ -90.1% |
| 2009 | 19.08x | Rp40.56 Billion | Rp2.13 Billion | ▲ +151.3% |
| 2008 | -37.22x | Rp-187.31 Billion | Rp5.03 Billion | ▼ -594.3% |
| 2007 | 7.53x | Rp83.42 Billion | Rp11.08 Billion | ▲ +56.9% |
| 2006 | 4.80x | Rp73.15 Billion | Rp15.24 Billion | ▲ +183.9% |
| 2005 | -5.72x | Rp-54.87 Billion | Rp9.59 Billion | ▼ -126.0% |
| 2004 | 22.00x | Rp159.25 Billion | Rp7.24 Billion | ▲ +8871.4% |
| 2000 | 0.25x | Rp27.05 Billion | Rp110.29 Billion | — |